Cargando…

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma

Glioma is one of the most common malignant tumors of the central nervous system, and its prognosis is extremely poor. Aberrant methylation of lncRNA promoter region is significantly associated with the prognosis of glioma patients. In this study, we investigated the potential impact of methylation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Meng, Sun, Libo, Huang, Kebing, Yue, Xiaoyu, Chen, Jie, Zhang, Zhengwei, Zhao, Bing, Bian, Erbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019920/ https://www.ncbi.nlm.nih.gov/pubmed/33828990 http://dx.doi.org/10.3389/fonc.2021.646409

Ejemplares similares

Identification of a mesenchymal-related signature associated with clinical prognosis in glioma
por: Zhang, Zhengwei, et al.
Publicado: (2021)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
por: Huang, Kebing, et al.
Publicado: (2021)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
por: Yang, Zhihao, et al.
Publicado: (2022)

Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
por: Yang, Zhihao, et al.
Publicado: (2023)

Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
por: Bian, Erbao, et al.
Publicado: (2021)

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
por: Wang, Jing, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature
por: Mao, Yu, et al.
Publicado: (2019)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
por: Chen, Zhigang, et al.
Publicado: (2023)

Differential Expression Profile of lncRNA in Glioma Cells and the Effect of lncRNA NKX3-1 on Glioma Cells Through Fem1b/SPDEF Pathway
por: Cai, Yang, et al.
Publicado: (2021)

A Novel Matrisomal-Related LncRNA Signature Associated With Survival Outcome and Immune Evasion in Patients With Gastric Cancer
por: Yang, Yuan, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer
por: Wang, Haixu, et al.
Publicado: (2021)

Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma
por: Li, Lianxin, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis
por: Li, Zhongyang, et al.
Publicado: (2021)

Novel three-lncRNA signature predicts survival in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2018)

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer
por: Zhang, Ruyue, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Survival analysis of immune-related lncRNA in low-grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis
por: Meng, Xinyao, et al.
Publicado: (2020)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ke5t4t9rtqbue9fq2eilqr4jjb